Mammalian target of rapamycin complex 1 orchestrates invariant NKT cell differentiation and effector function

Journal of Immunology

Volumn 193, Issue 4, 2014, Pages 1759-1765

  Zhang, Lianjun ^a   Tschumi, Benjamin O ^a   Corgnac, Stéphanie ^a   Rüegg, Markus A ^b   Hall, Michael N ^b   Mach, Jean Pierre ^a   Romero, Pedro ^a   Donda, Alena ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEVELOPMENTAL STAGE; EFFECTOR CELL; GENE FUNCTION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPROTEIN COMPLEXES; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TOR SERINE-THREONINE KINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905976831     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400769     Document Type: Article

References (41)

1. Bendelac, A., P. B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25: 297-336.
2. Godfrey, D. I., and S. P. Berzins. 2007. Control points in NKT-cell development. Nat. Rev. Immunol. 7: 505-518.
3. Salio, M., J. D. Silk, E. Y. Jones, and V. Cerundolo. 2014. Biology of CD1-And MR1-restricted T cells. Annu. Rev. Immunol. 32: 323-366.
4. Stirnemann, K., J. F. Romero, L. Baldi, B. Robert, V. Cesson, G. S. Besra, M. Zauderer, F. Wurm, G. Corradin, J. P. Mach, et al. 2008. Sustained activation and tumor targeting of NKT cells using a CD1d-Anti-HER2-scFv fusion protein induce antitumor effects in mice. J. Clin. Invest. 118: 994-1005.
5. Corgnac, S., R. Perret, L. Derré, L. Zhang, K. Stirnemann, M. Zauderer, D. E. Speiser, J. P. Mach, P. Romero, and A. Donda. 2013. CD1d-Antibody fusion proteins target iNKT cells to the tumor and trigger long-term therapeutic responses. Cancer Immunol. Immunother. 62: 747-760.
6. Constantinides, M. G., and A. Bendelac. 2013. Transcriptional regulation of the NKT cell lineage. Curr. Opin. Immunol. 25: 161-167.
7. F,inlay, D. K., A. P. Kelly, R. Clarke, L. V. Sinclair, M. Deak, D. R. Alessi, and D. A. Cantrell. 2010. Temporal differences in the dependency on phosphoinositide-dependent kinase 1 distinguish the development of invariant Valpha14 NKT cells and conventional T cells. J. Immunol. 185: 5973-5982.
8. Mycko, M. P., I. Ferrero, A. Wilson, W. Jiang, T. Bianchi, A. Trumpp, and H. R. MacDonald. 2009. Selective requirement for c-Myc at an early stage of V (alpha)14i NKT cell development. J. Immunol. 182: 4641-4648.
9. Gadue, P., N. Morton, and P. L. Stein. 1999. The Src family tyrosine kinase Fyn regulates natural killer T cell development. J. Exp. Med. 190: 1189-1196.
10. Eberl, G., B. Lowin-Kropf, and H. R. MacDonald. 1999. Cutting edge: NKT cell development is selectively impaired in Fyn-deficient mice. J. Immunol. 163: 4091-4094.
11. Dose, M., B. P. Sleckman, J. Han, A. L. Bredemeyer, A. Bendelac, and F. Gounari. 2009. Intrathymic proliferation wave essential for Valpha14+ natural killer T cell development depends on c-Myc. Proc. Natl. Acad. Sci. USA 106: 8641-8646.
12. Henao-Mejia, J., A. Williams, L. A. Goff, M. Staron, P. Licona-Limón, S. M. Kaech, M. Nakayama, J. L. Rinn, and R. A. Flavell. 2013. The microRNA miR-181 is a critical cellular metabolic rheostat essential for NKT cell ontogenesis and lymphocyte development and homeostasis. Immunity 38: 984-997.
13. Ziȩtara, N., M. Łyszkiewicz, K. Witzlau, R. Naumann, R. Hurwitz, J. Langemeier, J. Bohne, I. Sandrock, M. Ballmaier, S. Weiss, et al. 2013. Critical role for miR-181a/b-1 in agonist selection of invariant natural killer T cells. Proc. Natl. Acad. Sci. USA 110: 7407-7412.
14. Zhang, L., H. Zhang, L. Li, Y. Xiao, E. Rao, Z. Miao, H. Chen, L. Sun, H. Li, G. Liu, and Y. Zhao. 2012. TSC1/2 signaling complex is essential for peripheral naive CD8+ T cell survival and homeostasis in mice. PLoS One 7: e30592.
15. Wullschleger, S., R. Loewith, and M. N. Hall. 2006. TOR signaling in growth and metabolism. Cell 124: 471-484.
16. Betz, C., and M. N. Hall. 2013. Where is mTOR and what is it doing there? J. Cell Biol. 203: 563-574.
17. Dibble, C. C., W. Elis, S. Menon, W. Qin, J. Klekota, J. M. Asara, P. M. Finan, D. J. Kwiatkowski, L. O. Murphy, and B. D. Manning. 2012. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 47: 535-546.
18. Chen, H., L. Zhang, H. Zhang, Y. Xiao, L. Shao, H. Li, H. Yin, R. Wang, G. Liu, D. Corley, et al. 2013. Disruption of TSC1/2 signaling complex reveals a checkpoint governing thymic CD4+ CD25+ Foxp3+ regulatory T-cell development in mice. FASEB J. 27: 3979-3990.
19. Powell, J. D., K. N. Pollizzi, E. B. Heikamp, and M. R. Horton. 2012. Regulation of immune responses by mTOR. Annu. Rev. Immunol. 30: 39-68.
20. Chi, H. 2012. Regulation and function of mTOR signalling in T cell fate decisions. Nat. Rev. Immunol. 12: 325-338.
21. Yang, K., S. Shrestha, H. Zeng, P. W. Karmaus, G. Neale, P. Vogel, D. A. Guertin, R. F. Lamb, and H. Chi. 2013. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated metabolic reprogramming. Immunity 39: 1043-1056.
22. Delgoffe, G. M., T. P. Kole, Y. Zheng, P. E. Zarek, K. L. Matthews, B. Xiao, P. F. Worley, S. C. Kozma, and J. D. Powell. 2009. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30: 832-844.
23. Zeng, H., K. Yang, C. Cloer, G. Neale, P. Vogel, and H. Chi. 2013. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function. Nature 499: 485-490.
24. Polak, P., N. Cybulski, J. N. Feige, J. Auwerx, M. A. Rüegg, and M. N. Hall. 2008. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 8: 399-410.
25. Savage, A. K., M. G. Constantinides, J. Han, D. Picard, E. Martin, B. Li, O. Lantz, and A. Bendelac. 2008. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
26. Gordy, L. E., J. S. Bezbradica, A. I. Flyak, C. T. Spencer, A. Dunkle, J. Sun, A. K. Stanic, M. R. Boothby, Y. W. He, Z. Zhao, et al. 2011. IL-15 regulates homeostasis and terminal maturation of NKT cells. J. Immunol. 187: 6335-6345.
27. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20: 477-494.
28. Lee, Y. J., K. L. Holzapfel, J. Zhu, S. C. Jameson, and K. A. Hogquist. 2013. Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells. Nat. Immunol. 14: 1146-1154.
29. Schümann, J., M. P. Mycko, P. Dellabona, G. Casorati, and H. R. MacDonald. 2006. Cutting edge: influence of the TCR Vbeta domain on the selection of semiinvariant NKT cells by endogenous ligands. J. Immunol. 176: 2064-2068.
30. Matsuda, J. L., L. Gapin, N. Fazilleau, K. Warren, O. V. Naidenko, and M. Kronenberg. 2001. Natural killer T cells reactive to a single glycolipid exhibit a highly diverse T cell receptor beta repertoire and small clone size. Proc. Natl. Acad. Sci. USA 98: 12636-12641.
31. Wei, D. G., S. A. Curran, P. B. Savage, L. Teyton, and A. Bendelac. 2006. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition. J. Exp. Med. 203: 1197-1207.
32. Griewank, K., C. Borowski, S. Rietdijk, N. Wang, A. Julien, D. G. Wei, A. A. Mamchak, C. Terhorst, and A. Bendelac. 2007. Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development. Immunity 27: 751-762.
33. Shin, J., S. Wang, W. Deng, J. Wu, J. Gao, and X. P. Zhong. 2014. Mechanistic target of rapamycin complex 1 is critical for invariant natural killer Tcell development and effector function. Proc. Natl. Acad. Sci. USA 111: E776-E783.
34. Intlekofer, A. M., N. Takemoto, E. J. Wherry, S. A. Longworth, J. T. Northrup, V. R. Palanivel, A. C. Mullen, C. R. Gasink, S. M. Kaech, J. D. Miller, et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6: 1236-1244.
35. Zhu, J., D. Jankovic, A. J. Oler, G. Wei, S. Sharma, G. Hu, L. Guo, R. Yagi, H. Yamane, G. Punkosdy, et al. 2012. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity 37: 660-673.
36. Chang, C. H., J. D. Curtis, L. B. Maggi, Jr., B. Faubert, A. V. Villarino, D. O'Sullivan, S. C. Huang, G. J. Van Der Windt, J. Blagih, J. Qiu, et al. 2013. Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell 153: 1239-1251.
37. Araki, K., A. P. Turner, V. O. Shaffer, S. Gangappa, S. A. Keller, M. F. Bachmann, C. P. Larsen, and R. Ahmed. 2009. mTOR regulates memory CD8 T-cell differentiation. Nature 460: 108-112.
38. Yang, K., G. Neale, D. R. Green, W. He, and H. Chi. 2011. The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12: 888-897.
39. Coquet, J. M., S. Chakravarti, K. Kyparissoudis, F. W. McNab, L. A. Pitt, B. S. McKenzie, S. P. Berzins, M. J. Smyth, and D. I. Godfrey. 2008. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc. Natl. Acad. Sci. USA 105: 11287-11292.
40. Michel, M. L., D. Mendes-Da-Cruz, A. C. Keller, M. Lochner, E. Schneider, M. Dy, G. Eberl, and M. C. Leite-de-Moraes. 2008. Critical role of ROR-gt in a new thymic pathway leading to IL-17-producing invariant NKT cell differentiation. Proc. Natl. Acad. Sci. USA 105: 19845-19850.
41. Wu, J., J. Yang, K. Yang, H. Wang, B. Gorentla, J. Shin, Y. Qiu, L. G. Que, W. M. Foster, Z. Xia, et al. 2014. iNKT cells require TSC1 for terminal maturation and effector lineage fate decisions. J. Clin. Invest. 124: 1685-1698.